Somnomed Ltd has released a press release.
World first technology enabled oral appliance
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Somnomed
- North America Q2 revenue 36% amid regional variability
- Quarterly - revenue growth in key markets gains momentum
- Appendix 4C - quarterly
- Quarterly activities - Strong Q4 provides momentum into FY22
- Trading and operational activities improved over the quarter
Later from Somnomed
- Revenues on track despite COVID-19 disruptions
- Strong revenue growth and continued positive momentum
- Record Q4 and delivers on FY22 revenue guidance
- Quarterly Cash Flow Report
- FY22 results and FY23 guidance
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed